Legend Biotech (LEGN) Other Accumulated Expenses (2019 - 2025)

Legend Biotech (LEGN) has 7 years of Other Accumulated Expenses data on file, last reported at $1.0 million in Q4 2025.

• In Q4 2025, Other Accumulated Expenses rose 100.0% year-over-year to $1.0 million; the TTM figure through Dec 2025 stood at $1.0 million (up 100.0% YoY), while the FY2025 annual figure was $1.0 million, up 100.0% from the prior year.
• Other Accumulated Expenses was little changed at $1.0 million in Q4 2025, from $1.0 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $184.1 million in Q4 2022 and bottomed at $80096.0 in Q1 2021.
• A 5-year average of $90.8 million and a median of $119.6 million in 2023 frame the typical range for Other Accumulated Expenses.
• Annual changes were most pronounced in 2021 — Other Accumulated Expenses surged 128705.84% — and 2024, when it plunged 99.59%.
• Year by year, Other Accumulated Expenses stood at $123.6 million in 2021, then soared by 49.01% to $184.1 million in 2022, then tumbled by 33.57% to $122.3 million in 2023, then plunged by 99.59% to $500000.0 in 2024, then soared by 100.0% to $1.0 million in 2025.
• The last three Other Accumulated Expenses figures came in at $1.0 million (Q4 2025), $1.0 million (Q3 2025), and $138.8 million (Q2 2025), per Business Quant data.

Peer Comparison